Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers

  1. William Wan
  2. Mairi Clarke
  3. Michael J Norris
  4. Larissa Kolesnikova
  5. Alexander Koehler
  6. Zachary A Bornholdt
  7. Stephan Becker
  8. Erica Ollman-Saphire
  9. John AG Briggs  Is a corresponding author
  1. Vanderbilt University, United States
  2. EMBL, Germany
  3. La Jolla Institute of Immunology, United States
  4. Philipps-Universität Marburg, Germany
  5. Scripps Research Institute, United States
  6. La Jolla Institute for Immunology, United States
  7. MRC-LMB, United Kingdom

Abstract

Filoviruses such as Ebola and Marburg virus bud from the host membrane as enveloped virions. This process is achieved by the matrix protein VP40. When expressed alone, VP40 induces budding of filamentous virus-like particles, suggesting that localization to the plasma membrane, oligomerization into a matrix layer, and generation of membrane curvature are intrinsic properties of VP40. There has been no direct information on the structure of VP40 matrix layers within viruses or virus-like particles. We present structures of Ebola and Marburg VP40 matrix layers in intact virus-like particles, and within intact Marburg viruses. VP40 dimers assemble extended chains via C-terminal domain interactions. These chains stack to form 2D matrix lattices below the membrane surface. These lattices form a patchwork assembly across the membrane and suggesting that assembly may begin at multiple points. Our observations define the structure and arrangement of the matrix protein layer that mediates formation of filovirus particles.

Data availability

EM maps of VP40 from Ebola NP-VP24-VP35-VP40, VP40, VP40-GP VLPs and Marburg virions and VP40 VLPs were deposited in the EMDB with accession numbers EMD-11660, EMD-11661, EMD-11662, EMD-11663, EMD-11664, respectively. EM map of Ebola GP was deposited as EMD-11665. Crystal structures of eVP40 P62 and eVP40 P6422 were deposited to the PDB with accession numbers 7JZJ and 7JZT, respectively.

The following data sets were generated

Article and author information

Author details

  1. William Wan

    Department of Biochemistry, Vanderbilt University, Nashville, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2497-3010
  2. Mairi Clarke

    Structural and Computational Biology, EMBL, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9658-4308
  3. Michael J Norris

    La Jolla Institute of Immunology, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Larissa Kolesnikova

    Institute of Virology; German Center for Infection Research (DZIF) Gießen-Marburg-Langen Site, Philipps-Universität Marburg, Marburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Alexander Koehler

    Institute of Virology; German Center for Infection Research (DZIF) Gießen-Marburg-Langen Site, Philipps-Universität Marburg, Marburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Zachary A Bornholdt

    Scripps Research Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7557-9219
  7. Stephan Becker

    Institute of Virology; German Center for Infection Research (DZIF) Gießen-Marburg-Langen Site, Philipps-Universität Marburg, Marburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Erica Ollman-Saphire

    Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. John AG Briggs

    Structural Studies, MRC-LMB, Cambridge, United Kingdom
    For correspondence
    jbriggs@mrc-lmb.cam.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3990-6910

Funding

Medical Research Council (MC_UP_1201/16)

  • John AG Briggs

H2020 European Research Council (ERC-CoG-648432)

  • John AG Briggs

Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 1021)

  • Stephan Becker

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Wesley I Sundquist, University of Utah School of Medicine, United States

Publication history

  1. Received: May 22, 2020
  2. Accepted: October 2, 2020
  3. Accepted Manuscript published: October 5, 2020 (version 1)
  4. Version of Record published: October 26, 2020 (version 2)
  5. Version of Record updated: November 9, 2020 (version 3)

Copyright

© 2020, Wan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,312
    Page views
  • 302
    Downloads
  • 16
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. William Wan
  2. Mairi Clarke
  3. Michael J Norris
  4. Larissa Kolesnikova
  5. Alexander Koehler
  6. Zachary A Bornholdt
  7. Stephan Becker
  8. Erica Ollman-Saphire
  9. John AG Briggs
(2020)
Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
eLife 9:e59225.
https://doi.org/10.7554/eLife.59225

Further reading

    1. Microbiology and Infectious Disease
    Abdirahman I Abdi, Fiona Achcar ... Matthias Marti
    Research Article Updated

    The malaria parasite life cycle includes asexual replication in human blood, with a proportion of parasites differentiating to gametocytes required for transmission to mosquitoes. Commitment to differentiate into gametocytes, which is marked by activation of the parasite transcription factor ap2-g, is known to be influenced by host factors but a comprehensive model remains uncertain. Here, we analyze data from 828 children in Kilifi, Kenya with severe, uncomplicated, and asymptomatic malaria infection over 18 years of falling malaria transmission. We examine markers of host immunity and metabolism, and markers of parasite growth and transmission investment. We find that inflammatory responses associated with reduced plasma lysophosphatidylcholine levels are associated with markers of increased investment in parasite sexual reproduction (i.e. transmission investment) and reduced growth (i.e. asexual replication). This association becomes stronger with falling transmission and suggests that parasites can rapidly respond to the within-host environment, which in turn is subject to changing transmission.

    1. Evolutionary Biology
    2. Microbiology and Infectious Disease
    Olaya Rendueles, Jorge AM Moura de Sousa, Eduardo PC Rocha
    Research Article

    Many bacterial genomes carry prophages whose induction can eliminate competitors. In response, bacteria may become resistant by modifying surface receptors, by lysogenization, or by other poorly known processes. All these mechanisms affect bacterial fitness and population dynamics. To understand the evolution of phage resistance, we co-cultivated a phage-sensitive strain (BJ1) and a poly-lysogenic Klebsiella pneumoniae strain (ST14) under different phage pressures. The population yield remained stable after 30 days. Surprisingly, the initially sensitive strain remained in all populations and its frequency was highest when phage pressure was strongest. Resistance to phages in these populations emerged initially through mutations preventing capsule biosynthesis. Protection through lysogeny was rarely observed because the lysogens have increased death rates due to prophage induction. Unexpectedly, the adaptation process changed at longer time scales the frequency of capsulated cells in BJ1 populations increased again, because the production of capsule was fine-tuned, reducing the ability of phage to absorb. Contrary to the lysogens, these capsulated resistant clones are pan-resistant to a large panel of phages. Intriguingly, some clones exhibited transient non-genetic resistance to phages, suggesting an important role of phenotypic resistance in coevolving populations. Our results show that interactions between lysogens and sensitive strains are shaped by antagonistic co-evolution between phages and bacteria. These processes may involve key physiological traits, such as the capsule, and depend on the time frame of the evolutionary process. At short time scales, simple and costly inactivating mutations are adaptive, but in the long-term, changes drawing more favorable trade-offs between resistance to phages and cell fitness become prevalent.